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The N- and O-linked oligosaccharidcs in il yeast-derived HBsAg M protein (prc-S?. + S) wcrc analyzed. Two major structures of the /V-linked 
oligosaccharides bound to residue A& were determined IO bc high-mannose type oligosaccharidcs. Man,GlcNAcz and Man&lcNAc2, by 
two-dimensional sugar mapping of the corresponding pyridylamino ligosacchuridcs. Pcptidc mapping of the M protein, scquencc analysis of the 
glycopeptides after b-elimination under rcduciny conditions and sugar-composition analysis revealed that the O-linked oligosaccharidcs were 
composed solely of mannosc and bound to residue Scr’, Tht”. Thr’. Scr”, ScrzX, Scr~ and Thr3’ in the prc-S2 region. 
Hepatitis I3 vaccine: Prc-S2 ff- and O-linked oli~osaccl~arides 
1. INTRODUCTION 
Infection with hepatitis I3 virus (HBV) is a worldwide 
health problem which is especially serious in Soulheast 
Asia, the Middle East and Africa. To date various 
hepatitis B (HB) vaccines have been developed using a 
variety of immunogens: HBV surface antigen (HBsAg) 
small particles from healthy carriers {first-generation 
HB vaccine), yeast-derived HBsAg S protein particles 
(second-generation HB vaccine) II-41 and yeast or 
mammalian cell-derived HBsAg M protein (pre-S2 + S) 
particles (third-generation HB vaccine) f5-91. 
We have already reported the purification and char- 
acterization of recombinant yeast-derived modified M 
protein particles (HBsAg M-P3Ic). M-P3lc was found 
to be composed mainly of two major glycoproteins, 
GP37 and GP34. Protein chemical analyses of these 
glycoproteins revealed that (1) GP37 and GP34 have the 
same polypcptide backbone, P31, (2) GP37 has an N- 
linked oligosaccharide bound to Asn’ and an additiona 
~-li~lked oligosaccharide[s) bound to the pre-§2 region 
of P31, and (3) GP34 has an ~-linked oligosaccharide 
bound to Asn [7j. However, the structures of these 
oligosaccharides and the binding sites of O-linked oligo- 
saccharides have until now remained unresolved, 
Two-dimensional sugar mapping of the pyridylamino 
(PA)-oligosaccharides revealed that Asn” has a high- 
mannose type oligosaccharide, ither Man,GlcN.Q or 
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Man,GlcNAq. In this report, we describe the structures 
of the two major IV-linked oligosaccharides and the 
binding sites of the O-linked oligosaccharides. 
2. MATERIALS AND METHODS 
HBsAg M-P3lc particles were prepared from recombinant yeast 
according to the method described in [I]. TPCK-trypsin was pur- 
chased from Millipore, pepsin from Sigma and endo-~-~-~t~l~y- 
co~n~inidase H (endo ii) from Seikagaku Kogyo Co.. Ltd. Other 
chemicals were purchased from Wnko Pure Chemical Industries. Ltd. 
OliBosacchirridcs released from HBsAg M-P3lc by hydraxinolysis 
were N-acetylatcd with acetic anhydride nnd coupled with Z-amino- 
pyridine by the method of Hase ct al. [IO]. The reaction mixture was 
extracted three times with ethyl acetate. and fractions containing PA- 
oligosaccharidcs were obtained by Asahipak GS-220 column (Asahi 
Chemical Industry Co., Ltd.) chromatography. 
23. SI~USIU~L~ ducidu~iott q/’ PAaliilosaccilurirlc?s 
Structure elucidation of PA~l~~osa~harid~ was performed ac- 
cording to the method of Tomiytt et al. [Ill. In brief, PA-oliBosac- 
charides were purist using a TSK-gel amide-80 column {amide silica 
column; 0.44 x IS cm; Tosoh), and peak fractions were further ana- 
lyzed using a Shimpak CLC-ODS column (ODS silica catumn; 0.6 x 
IS cm). PA-oligosaccharides were detected by Ruorcscence using cxci- 
cation and emission wavelength of 320 and 400 nm, respectively. The 
glucose units were determined by comparing the elution positions of 
each PA-oligosuccharide on both amide silica and ODS silica columns 
with those of standard PA-&ICOSC oligomers and were plotted on a 
two-dimensional sugar map. The structures of the oligosaccharides 
Here estimated with aid of the sugar mp described in [I I]. 
2.4. Prqwuu’br~ of srurtllrrrrl PA-@ICOSU oiigontcr.~ 
Dextran ( I00 mg) was dissolved in I ml of 0.1 N HCI and hydro- 
lyzed in vacua at lOU”C for 4 h, The r~ultinS mixture of S~UCDSC 
oli6~ll~ers was subjected to coupling with ~-a~nopyrid~ne. 
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Fig. 1. Structure dctcrminution oC R-linked oliyoeuccharidcs. (A) Amide nilictt chron~utoyruphy of PA-oligosuccharidcs, Prcparution of PA- 
oliyosucchttrides is dcscribcd in section ’ 2, PA.oliyosaecharidcs wcrc loaded onto u TSK.gel ttmide-80 column previously equilibrated with 21 mixture 
of3% CH,COOH-tricthylemine bull& (pH 7,3) and CHCN (35:6S. v/v), PA-olil?osacchurides wet-c clutcd by increasing the ratio or 3% CHJOOH- 
triethylaminc buffer (pH 7.3) to CH)CN l’rom 35:65 to 5O:SO. Fructions l’or two puuks, dcsignatcd PA-I and PAZ, wcrc collcctcd for further analysis, 
(B) ODS silica chromatography of PA-I and PA-2. PA- I and PA-2 were loaded onto tt Shimptk CLC-ODS column previously equilibrated with 
IO tnM sodium phosphutc buffer (pH 3.8). 0.1% I-butanol. The PA-oli&osdcchJridcs were elutcd by using a yrddicnl of I-bumnol concentration 
from 0.1% to 0.25%. * and ** are peaks used for detccmininy glucose units. (C) Two~dimcnsionul sugar ni;~p of PA-I and PA-2. The glucose units 
were dctcrmined by comparing the elution positions of PA-I and PA-2 on both ttmidc silica and ODS silicu columns with those of standard 
PA-glucose oligomcrs. The glucose units ol’ PA-I und PA-2 arc plolted on a two-dimcnsionul sugar map according to the method of 
Totniyu ct al. [! I], 
PA-oligosaccharides wcrc hydrolyzed in vxuo in 4 M trifruoroocc- 
tic acid (TFA) at 100°C Tar 4 h, Monosucchnridcs released wcrc 
analyrcd using the BioLC system (Dionex) equipped with a CurboPak 
PA-L column, 
HBsAg M-F3 Ic (6.1 mg) was incubated with cndo H at an enzyme 
to substrate ratio (E/S) of 1:1000 (w/w) at 37°C l’or 20 h to reniove the 
N-linked oligosaccharider and was digested further *v.+!h TPCK-tryp- 
sin at an E/S ratio of ):I000 (W/W) ii1 37°C for ah ndditional 5 h. 
Met’-Arg’” was purified by HPLC usinB a Nuclcosil SC18 column (0.4 
x 30 cm: Macherey-Nage) Company). 
HBsAg M-P3lc (30 mg) WPS digested with TPCK-trypsin at an E/S 
ratio of I:?50 (w/w) at 37OC for 2 h. TPCK.trypsin and sm:dl molcc- 
ular-weight tryptic pcptides were rcmovcd by Scphucryl S-300 ~olu~nn 
chromutography. The thus purified des-(Met’-Arg’“) M-P3lc was 
diulyzcd against PBS, and the pH was adjusted to 2.5. Dca-(Met’. 
Argt”) M-P3lc was digested with pepsin at an E/S ratio of I:50 (w/w) 
at 37°C for 3 h. The reaction was stopped by adjusting the pH to 7.7. 
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itnd Gly’“~Glu” wus purilicd by alhnity chromatography using a Con 
A Sephtrrosc (Vb = I5 ml; Phttrmttcitt) column and HPLC using tt 
YMC-puckcd A324.ODS column (YMC Co., Ltd), 
~-Elimination ol’ the O-linked oligosaccharides or Met’-A&’ and 
Gly”‘-Glu”’ wts pcrl’ormed under reducing conditions according to the 
methods dcscribcd in [I21 und [I?& Etch glycopeptidc (20 nmol) Yyds 
dissolved in 0.8 ml of 0. I M NuOH. 0.3 M NuBHJ, and 1.7 mg of 
Palladium black was added. The reaction was allowed to proceed at 
room tcmperrrture for i9 h under a Nz atmosphere and was stopped 
by adding ft.4 ml of I ?vl AcOH. Palladium blrck was removed by 
centriTug;uion, und dcglycosylatcd peptide was purified by rcvcrsc- 
phase HPLC. 
The Wtcrminttl umino wcid sequence was determined with a gas- 
phusc protein scrlucncer model 470A coupled with a model l20A 
unalyzcr (Applied Biosystcms, Inc,). Amino acid composition was 
dctcrmincd with a PICO-TAG amino acid analysis system (Millipcsrc! 
aflcr hydrolysis of the sample. 
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Fig. 2, Structures of N-linked oligosaccharidcs of HEsAg MaP3lc. 
(A) PA-I; (6) PA-2 
3. RESULTS AND DISCUSSION 
3.1. Sr~~rurc rluci~kutiorz 0J N-ii&d oligosucciwides 
Sugar composition of these oligosaccharides deter- 
We previously reported that an N-linked oligosac- 
charide was bound to residue Asn” of the polypeptidc 
mined after hydrolysis of PA-I and PA-2 at 100°C for 
backbone P31 based on peptide mapping, glycosidase 
digestion and sugcr composition analysis [7]. To eluci- 
4 h in 4 M TFA indicated that the mannose/glucosa- 
date the structure of the %linkcd oligosaccharide, M- 
P3 Ic was degraded by hydrazinolysis, and the oligosac- 
mine ratios for PA-1 and PA-2 were 7.&l. I and 
charides released were N-acetylated and modified by 
2-aminopyridine according to the method of Hase et al. 
8.CkO.95, respectively. This is consistent with the results 
[!O]. Fig. IA shows the elution profile of PA-oligosac- 
charides from an amide silica column. The major PA- 
described above. (GlcNAc at the reducing end was con- 
oligosaccharides. PA-I and PA-2, were collected sepa- 
rately and subjected to ODS silica column chromatog- 
verted into a PA-derivative by pyridylamination and 
raphy (Fig. 1 B). The glucose units of PA-I and PA-2 for 
both amide silica and ODS silica columns were deter- 
was not detected in this assay.) 
mined using a PA-glucose oligomer mixture as the 
standard and were plotted on a two-dimensional sugar 
map (Fig. IC). The structures of PA-I and PA-2 were 
estimated to be those shown in Fig. 2A and Fig. 2B, 
respectively, with the aid of the sugar map described in 
[I 11. PA-l and PA-2 are typical high-mannose type oli- 
gosaccharides. Outer chains composed of a number of 
mannose residues are often observed in glycoproteins of 
yeast origin. The oligosaccharides in M-P3lc do not 
have such outer chains which might hinder the vaccine’s 
ability to elicit anti-S and anti-pre-S2 antibodies. 
HBsAg M-P3 Ic contains O-linked oligosaccharides 
in the pre-S2 region as well as N-linked oligosaccharides 
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Fig. 3. N-tcrmin;il acid scqucnccs of glycopeptides, Met’-A#’ (A) 
and Gly”‘4Iilu”’ (6). (I) Putative amino acid sequcncc derived from 
the DNA scqucncc: (2) Amino acid scqucncc obtained alicr/&elimina- 
tion. X. unidcntiticd: ABA. Ltminabutyric acid. Glycosylation sites 
are indicated by the bows, SC? und ThP for A and SC? for B were 
also idcntificd upon sequencing after @,4imination. 
as evidenced by peptide mapping [7]. To precisely deter- 
mine the O-linked oligosaccharide binding sites, we 
Yu lp et al. recently reported the structures of Iv- 
tried to isolate glycopeptides having O-linked oligosac- 
charides. M-P3 lc was treated with endo H to remove 
linked oligosaccharides in a recombinant M protein 
N-linked oligosaccharides, and Met’-Arg’” was purified 
from the digest by reverse-phase HPLC. Alternatively, 
produced by the mnn9 sirain of Succlrurorrzjces cerevi- 
M-P3Ic was first digested with trypsin then with pepsin, 
and Gly”-GIu~’ was purified from the digest by Con A 
siue [IS]. They found that the major structures of the 
affinity column chromatography and reverse-phase 
HPLC. N-terminal amino acid sequence analysis after 
IV-linked oligosaccharides were Man,GlcNAc? and 
/&elimination of these glycopeptides gave PTH-Ala at 
residue numbers 5, 27, 28 and 29 and PTH-Zaminobu- 
Man,GIcNAcz. similar to our observations. However, 
tyric acid (ABA) at 6, 7 and ?! (Fig:. 3). These results 
clearly indicate that the O-linked oligosaccharides were 
they did not investigate the O-linked oligosaccharides 
bound to Ser5, Thr”. Se?‘, Se?“, Se?’ and Thr3’. be- 
cause a Ser residue with an O-linked oligosaccharide is
in their M protein. 
converted into Ala, and Thr into ABA, upon@limina- 
tion under reducing conditions. We also observed PTH- 
Ser at residues 5 and 27 and PTH-Thr at residue 6 after 
B-elimination (Fig. 3). This suggests that there is heter- 
ogeneity with regard to the O-glycosylation sites. Sugar 
composition analysis revealed that the O-linked oligo- 
saccharides were composed of only mannose. 
In conclusion, M-P31c has an N-linked oligosac- 
charide. either Man,Glcl\l& or Man,GlcNAe. bound 
to residue Asn’ and O-linked oligosaccharides bound 
variably to Ser5-Thr’ and Ser5’-Thr”. These oligosac- 
charidcs do not have any effect on the ability of the 
i31 
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HBsAg M-P3 Ic \ ~xd!x to elicit anti-S and anti-pre-S3 
antibodies in experimental nimals (Kobayashi et al., to 
be published elsewhere). Structural analysis of the 0 
linked oligosaccharides remains to be elucidated. 
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